SRAD Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
SRAD is not a good buy right now for a Beginner long-term investor with $50,000-$100,000 available. The stock has some supportive signals from insider buying and bullish options positioning, but the current setup is dominated by bearish news flow, falling analyst price targets, and a weak technical trend. Since there is no strong Intellectia buy signal today and the user wants a direct answer without waiting for the perfect entry, my view is to hold off for now rather than buy into the current uncertainty.
Pre-market price is 13.09, essentially flat to slightly higher. The RSI_6 is 50.7, which is neutral and shows no momentum edge. MACD histogram is positive at 0.166 but contracting, suggesting upside momentum is weakening. The moving average structure is bearish with SMA_200 > SMA_20 > SMA_5, indicating the broader trend remains weak. Pivot support/resistance is tight around the current price, with support at 12.567 and resistance at 13.545, so the stock is trading in a narrow, indecisive range rather than breaking out.
Insiders are buying, and the buying amount increased 404.06% over the last month, which is a meaningful positive signal. Options data is bullish with low put-call ratios. There is also a modest pre-market gain and a short-term model suggesting a possible 10.44% move over the next month. Some analysts still maintain Buy ratings despite reducing targets, which shows the company is not being abandoned entirely by Wall Street.
The biggest negative catalyst is the class action lawsuit filed on May 28-29, 2026, alleging securities fraud and ties to black-market gambling operators. That creates major headline and legal overhang. Analyst sentiment has clearly deteriorated: JPMorgan downgraded the stock to Neutral, Morgan Stanley cut its target sharply, and several firms lowered targets after a mixed Q1 report. Technical trend is also weak, with bearish moving averages and no strong momentum signal. Hedge funds are neutral, so there is no strong institutional accumulation trend.
Latest quarter appears to be Q1 2026 based on the analyst notes. The company reported mixed to soft Q1 results, with revenue and adjusted EBITDA both below consensus. FX headwinds reduced reported revenue growth by about 5 percentage points. Management reiterated FY26 guidance, which some analysts viewed as conservative, but others saw the quarter as raising risk to the outlook. Overall, growth is still present, but the latest quarter did not show strong execution.
Wall Street sentiment has shifted from mostly bullish to mixed/neutral. JPMorgan downgraded SRAD to Neutral from Overweight with a $16 target, while Morgan Stanley cut its target to $16 and kept Equal Weight. Other firms like UBS, Deutsche Bank, Truist, Benchmark, Guggenheim, Stifel, and Canaccord still have Buy ratings, but nearly all reduced their price targets materially. The pros view is that Sportradar still has strategic upside and some analysts think guidance is conservative. The cons view is that valuation is not improving quickly, near-term upside looks limited, and execution plus patience are required. Net: analyst tone is cautious, not strongly bullish.
